Delisting risk
Basel Medical Group (BMGL)
Provides orthopedic, neurosurgical and primary-care services through Singapore clinics.
$4.97
Pre-market+0.01 (+0.20%)
At close$4.96(−2.36%)
In millions of USD, except per-share figures · converted from SGD at the latest rate
| In millions | Q4 FY24Jun 2025 | Q2 FY25Dec 2025 |
|---|---|---|
| Revenue | 5 | 6 |
| Cost of revenue | 4 | 7 |
| Gross profit | 1 | −1 |
| 2 | 2 | |
| Selling, general & administrative | 2 | 2 |
| Operating income | — | −2 |
| — | 3 | |
| Interest income | 0 | 0 |
| Interest expense | 0 | 0 |
| Income before tax | −8 | 0 |
| Income tax expense | 0 | 0 |
| Net income from continuing operations | −8 | 0 |
| Net income | −8 | 0 |
| EPS, basic | −$0.41 | $0.13 |
| EPS, diluted | −$0.41 | $0.13 |
| Weighted average shares, basic | 19 | 2 |
| Weighted average shares, diluted | 19 | 2 |
| EBITDA | −1 | −1 |
| Depreciation & amortization | 1 | 2 |
| EBIT | — | −2 |